Consumers reluctant to try new weight loss drugs seem to focus more on the least likely risks such as pancreatitis and a rare type of thyroid cancer rather than focusing on the more common side effects like burping, nausea, vomiting, constipation and diarrhea. In actuality, they should focus on the more life-threatening risks associated with obesity and NOT taking the medication: cancer.

Why would Mississippi and West Virginia, states that are ranked #1 and #4 in poverty, #5 and #1 in adult obesity, and #2 and #4 in adolescent obesity, respectively, eliminate access to the most affordable version of the safe and effective weight loss drugs Ozempic and Wegovy?

We discuss an alert by the FDA and two other recent actions taken against compounding pharmacies and providers who offer semaglutide, the active ingredient found in Ozempic and Wegovy. While NovoNordisk, the makers of Ozempic, Wegovy and even the oral version of semaglutide, would like to push the narrative that this is about safety, based on the suits, this is clearly a campaign of harassment to protect their interests.

Increase your patient base: Adding a weight management program to an aesthetic practice can help attract a new population of patients who are looking to improve their appearance and health through weight management. If your current practice offers weight loss surgery, then you already realize not every potential patient is a good candidate right away. Adding a non-surgical weight management option is a great alternative to allow you to serve even more patients.

Since implementation of the No Surprises Act (NSA) on January 1st, 2022, there have been four lawsuits brought on by the Texas Medical Association (TMA). Interesting that the TMA is more vocal and active legally and supportive of physicians in America than the American Medical Association (AMA).  Not sure why anyone would pay dues to the AMA… but I digress. The NSA is designed to minimize surprise bills in three circumstances and the TMA lawsuits focus on the IDR process after emergency care.

The No Surprises Act (NSA) went in to effect January 1st 2022. For those unfamiliar… the No Surprises act is an effort to reduce the number of surprise bills that patients are faced with after their procedure. Even after a year of implementation the Act is still largely overlooked by most medical offices, providers, and most importantly patients. Read more about the new price transparency requirements it includes.